{"id":"https://openalex.org/W3083388744","doi":"https://doi.org/10.1158/1538-7445.am2020-4562","title":"Abstract 4562: Next generation Oncos oncolytic adenovirus with novel anti-cancer double-transgenes shows synergistic anticancer effect in melanoma mouse model","display_name":"Abstract 4562: Next generation Oncos oncolytic adenovirus with novel anti-cancer double-transgenes shows synergistic anticancer effect in melanoma mouse model","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083388744","doi":"https://doi.org/10.1158/1538-7445.am2020-4562","mag":"3083388744"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-4562","doi":"https://doi.org/10.1158/1538-7445.am2020-4562","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-4562","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035158988","display_name":"\u0141ukasz Kuryk","orcid":"https://orcid.org/0000-0003-1887-6361","observed_orcids":["https://orcid.org/0000-0003-1887-6361"]},"institutions":[{"id":"https://openalex.org/I4210129595","display_name":"Targovax (Finland)","ror":"https://ror.org/033q3j448","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210129595","https://openalex.org/I4210158062"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Lukasz Kuryk","raw_affiliation_strings":["1Targovax Oy, Helsinki, Finland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Targovax Oy, Helsinki, Finland;","institution_ids":["https://openalex.org/I4210129595"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055496818","display_name":"Anne\u2010Sophie W. M\u00f8ller","orcid":"https://orcid.org/0009-0007-4507-1055","observed_orcids":["https://orcid.org/0009-0007-4507-1055"]},"institutions":[{"id":"https://openalex.org/I4210158062","display_name":"Targovax (Norway)","ror":"https://ror.org/05nkrhe64","country_code":"NO","type":"company","lineage":["https://openalex.org/I4210158062"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Anne-Sophie Moller","raw_affiliation_strings":["2Targovax ASA, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Targovax ASA, Oslo, Norway","institution_ids":["https://openalex.org/I4210158062"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"4562","last_page":"4562"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-adenovirus","display_name":"oncolytic adenovirus","score":0.9810000061988831},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9520000219345093},{"id":"https://openalex.org/keywords/immunogenic-cell-death","display_name":"immunogenic cell death","score":0.8230000138282776},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.652999997138977},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.781000018119812},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9769999980926514},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.6380000114440918},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.6449999809265137},{"id":"https://openalex.org/keywords/costimulatory-molecules","display_name":"costimulatory molecules","score":0.6660000085830688},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.49300000071525574},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.4909999966621399}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.980610191822052},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6386876106262207},{"id":"https://openalex.org/C49744831","wikidata":"https://www.wikidata.org/wiki/Q600121","display_name":"Virotherapy","level":4,"score":0.615326464176178},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6005674600601196},{"id":"https://openalex.org/C2777283488","wikidata":"https://www.wikidata.org/wiki/Q7095181","display_name":"Oncolytic adenovirus","level":4,"score":0.5901637077331543},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5787925124168396},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5632956027984619},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5363131165504456},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.521918773651123},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.5135941505432129},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4487060308456421},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.42724689841270447},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.38081517815589905},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31560927629470825},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08508819341659546},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-4562","doi":"https://doi.org/10.1158/1538-7445.am2020-4562","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-4562","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6960087520","https://openalex.org/W4320233965","https://openalex.org/W4293769478","https://openalex.org/W4318208104","https://openalex.org/W2623190060","https://openalex.org/W7131895718","https://openalex.org/W2806545858","https://openalex.org/W2962961581","https://openalex.org/W4415278667","https://openalex.org/W4353033989"],"abstract_inverted_index":{"Abstract":[0],"Oncolytic":[1],"virotherapy":[2],"is":[3,25,48],"a":[4,58],"promising":[5,41],"anti-cancer":[6,180,320],"strategy":[7],"utilizing":[8],"genetically":[9],"engineered":[10,71,95],"viruses":[11,162],"to":[12,82,109,176,208,224,237,272,276,279,289,299],"preferentially":[13],"infect,":[14],"replicate":[15],"in":[16,43,65,80,122,125,141,146,166,193,197,211,213,265,326],"and":[17,102,113,120,124,130,137,152,170,181,190,200,219,228,258,263,295,302,348],"lyse":[18],"cancer":[19],"cells.":[20],"To":[21],"date,":[22],"Talimogene":[23],"laherparepvec":[24],"the":[26,84,90,118,161,179,186,216,233,266,291,334,338],"only":[27],"FDA":[28],"approved":[29],"oncolytic":[30,133,316],"virus":[31],"(OV),":[32],"however,":[33],"many":[34],"other":[35],"types":[36],"of":[37,128,135,154,160,185,222,241,260,293,333,337],"OVs":[38,72],"are":[39],"showing":[40],"results":[42],"clinical":[44,305],"studies.":[45],"One":[46],"example":[47],"ONCOS-102,":[49],"an":[50,270],"adenovirus":[51,317],"serotype":[52],"5/3":[53],"chimera":[54],"expressing":[55,104,249,253],"GM-CSF":[56],"as":[57],"transgene,":[59],"which":[60],"recently":[61],"reported":[62],"33%":[63],"ORR":[64],"advanced":[66],"anti-PD1":[67],"refractory":[68],"melanoma.":[69],"Genetically":[70],"can":[73],"be":[74,286],"armed":[75],"with":[76,215,318],"different":[77],"co-stimulatory":[78],"molecules":[79],"order":[81],"boost":[83],"anti-tumour":[85],"immune":[86,182,243],"responses.":[87],"Building":[88],"on":[89],"ONCOS-102":[91],"backbone,":[92],"we":[93,116],"have":[94],"two":[96],"next":[97],"generation":[98,314],"ONCOS":[99],"viruses,":[100],"ONCOS-210":[101,129,136,189,301],"ONCOS-212,":[103],"novel":[105,319],"double":[106,204],"transgenes":[107,205],"designed":[108],"inhibit":[110],"tumor":[111,230,239],"growth":[112],"metabolism.":[114],"Here,":[115],"describe":[117],"characterization":[119],"pre-clinical":[121],"vitro":[123],"vivo":[126],"testing":[127],"ONCOS-212.":[131],"The":[132,203],"properties":[134],"ONCOS-212":[138,191,303],"were":[139,163,206,235],"confirmed":[140],"4":[142],"melanoma":[143,327],"cell":[144,150,156,226],"lines":[145],"vitro,":[147],"demonstrating":[148],"robust":[149,194],"lysis":[151,227],"induction":[153],"immunogenic":[155],"death.":[157],"Anti-cancer":[158],"effects":[159],"also":[164],"assessed":[165],"i)":[167],"immunodeficient":[168],"xenograft":[169,173],"ii)":[171],"humanized":[172],"mouse":[174,328],"models":[175],"further":[177,287],"understand":[178],"stimulatory":[183],"potency":[184],"constructs.":[187],"Intra-tumoral":[188],"resulted":[192],"anti-tumor":[195],"activity":[196],"both":[198],"immune-deficient":[199],"immune-competent":[201],"mice.":[202],"shown":[207],"act":[209],"synergistically":[210],"vivo,":[212],"line":[214],"design":[217],"hypotheses":[218],"proposed":[220],"mode":[221,292],"action":[223,294],"induce":[225],"prevent":[229],"growth.":[231],"Moreover,":[232],"vectors":[234],"able":[236],"increase":[238],"infiltration":[240],"various":[242],"subsets":[244],"including":[245],"CD4+,":[246],"CD8+,":[247],"CD8+":[248,252],"PD1+":[250],"or":[251],"Granzyme":[254],"B":[255],"T":[256],"cells":[257],"reduction":[259],"regulatory":[261],"T-cells":[262],"MDSC":[264],"tumour":[267],"microenvironment,":[268],"suggesting":[269],"ability":[271],"prime":[273],"immune-suppressive":[274],"tumors":[275],"better":[277],"respond":[278],"immunotherapy.":[280],"These":[281],"encouraging":[282],"preclinical":[283],"findings":[284],"will":[285],"investigated":[288],"elucidate":[290],"perform":[296],"toxicological":[297],"studies":[298],"bring":[300],"towards":[304],"testing.":[306],"Citation":[307],"Format:":[308],"Lukasz":[309],"Kuryk,":[310],"Anne-Sophie":[311],"Moller.":[312],"Next":[313],"Oncos":[315],"double-transgenes":[321],"shows":[322],"synergistic":[323],"anticancer":[324],"effect":[325],"model":[329],"[abstract].":[330],"In:":[331],"Proceedings":[332],"Annual":[335],"Meeting":[336],"American":[339],"Association":[340],"for":[341],"Cancer":[342,354],"Research":[343],"2020;":[344],"2020":[345],"Apr":[346],"27-28":[347],"Jun":[349],"22-24.":[350],"Philadelphia":[351],"(PA):":[352],"AACR;":[353],"Res":[355],"2020;80(16":[356],"Suppl):Abstract":[357],"nr":[358],"4562.":[359]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-09-11T00:00:00"}